NMR regulatory analysis: Determination and characterization of chinese-herb aristolochic acids

Pharmazie

Volumn 59, Issue 3, 2004, Pages 170-174

  Hanna, George M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; MALEIC ACID; PROTON; SODIUM; VINYL DERIVATIVE;

ACCURACY; ARISTOLOCHIA; ARTICLE; CHINESE MEDICINE; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; HERBAL MEDICINE; METHODOLOGY; NEPHROTOXICITY; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROMETRY; STANDARD;

ALGORITHMS; ARISTOLOCHIC ACIDS; CHROMATOGRAPHY, THIN LAYER; DIMETHYL SULFOXIDE; DRUGS, CHINESE HERBAL; MAGNETIC RESONANCE SPECTROSCOPY; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 1642371213     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Abel G, Schimmer O (1983) Induction of structural chromosome aberrations and sister chromatid exchanges in human lymphocytes in vitro by aristolochic acid. Hum Genet 64: 131-133.
2. Burlinson B (1989) An in vivo unscheduled DNA synthesis (UDS) assay in the rat gastric mucosa: preliminary development. Carcinogenesis 10: 1425-1428.
3. De Broe ME (1999) On a nephrotoxic and carcinogenic slimming regimen. Am J Kidney Dis 33: 1171-1173.
4. Gotzl E, Schimmer O (1993) Mutagenicity of aristolochic acids (I, II) and aristolic acid I in new YG strains in Salmonella typhimurium highly sensitive to certain mutagenic nitroarenes. Mutagenesis 8: 17-22.
5. Hashimoto H, Higichi M, Makono B, Sakakibara I, Kubo M, Komatsu Y, Maruno M, Okada M (1999) Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. J Ethnopharmacol 64: 185-189.
6. Kluthe R, Vogt A, Batsford S (1982) Double blind study of the influence of aristolochic acid on granulocyte phagocytic activity. Arzneimittelforsch 32: 443-445.
7. Krumbiegel G, Hallensleben J, Mennicke WH, Rittmann N, Roth HJ (1987) Studies on the metabolism of aristolochic acids I and II. Xenobiotica 17: 981-991
8. Lord GM, Tagore R, Cook T, Gower P, Pusey CD (1999) Nephropathy caused by Chinese herbs in the UK. Lancet. 354: 481-482.
9. Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL (2000) Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 17: 408-412.
10. Mengs U (1983) On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch Toxicol 52: 209-220.
11. Mengs U (1987) Acute toxicity of aristolochic acid in rodents. Arch Toxicol 59: 328-331.
12. Mengs U, Stotzem CD (1993) Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology. Arch Toxicol 67: 307-311.
13. Nortier JL, Martinez M-CM, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem J-L (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342: 1686-1692.
14. Nortier JL, Schmeiser HH, Muniz Martinez MC, Arlt VM, Vervaet C, Garbar CH, Daelemans P, Vanherweghem JL (2003) Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant 18: 426-428.
15. Pezzuto JM, Swanson SM, Mar W, Che CT, Cordell GA, Fong HH (1988) Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives. Mutat Res 206: 447-454.
16. Pfau W, Schmeiser HH, Wiessler M (1990) 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. Carcinogenesis 11: 1627-1633.
17. Pool BL, Eisenbrand G, Preussmann R, Schlehofer JR, Schmezer P, Weber H, Wiessler M (1986) Detection of mutations in bacteria and of DNA damage and amplified DNA sequences in mammalian cells as a systematic test strategy for elucidating biological activities of chemical carcinogens. Food Chem Toxicol 24: 685-691.
18. Routledge MN, Orton TC, Lord PG, Garner RC (1990) Effect of butylated hydroxyanisole on the level of DNA adduction by aristolochic acid in the rat forestomach and liver. Jpn J Cancer Res 81: 220-224.
19. Rücker VG, Chung BS (1975) Aristolochic acids from Aristolochia manshuriensis. Planta Med. 27: 68-67.
20. Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP (1996) Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 56: 2025-2028.
21. Schmeiser HH, Pool BL, Wiessler M (1986) Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. Carcinogen 7: 59-63.
22. Stengel B, Jones E (1998) End-stage renal insufficiency associated with Chinese herbal consumption in France. Nephrologie 19: 15-20.
23. Stiborova M, Frei E, Breuer A, Wiessler M, Schmeiser HH (2001) Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase - (32)P-post labeling analysis of DNA adduct formation. Mutat Res 493: 149-160.
24. Tanaka A, Nishida R, Maeda K, Sugawara A, Kuwahara T (2000) Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy? Clin Nephrol 53: 301-306.
25. Vanherweghem LJ (1998) Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 4: 9-13.
26. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R, et al. (1993) Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 341: 387-391.
27. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL (1994) Identification of aristolochic acid in Chinese herbs. Lancet 343: 174.
28. Yang CS, Lin CH, Chang SH, Hsu HC (2000) Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 35: 313-318.
29. Zhu M, Phillipson JD (1996) Hong Kong samples of the traditional Chinese medicine "Fang Ji" contain aristolochic acid toxins. Int J Pharmacognosy 34: 283-289.